JPH02502913A - 無機塩類および酢酸を主成分とする、ウイルス性疾患の予防および治療用の水性製剤 - Google Patents
無機塩類および酢酸を主成分とする、ウイルス性疾患の予防および治療用の水性製剤Info
- Publication number
- JPH02502913A JPH02502913A JP1500765A JP50076588A JPH02502913A JP H02502913 A JPH02502913 A JP H02502913A JP 1500765 A JP1500765 A JP 1500765A JP 50076588 A JP50076588 A JP 50076588A JP H02502913 A JPH02502913 A JP H02502913A
- Authority
- JP
- Japan
- Prior art keywords
- aqueous solution
- ions
- acetic acid
- prepared
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title abstract description 21
- 201000010099 disease Diseases 0.000 title abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract description 7
- 230000003612 virological effect Effects 0.000 title abstract description 7
- 238000002360 preparation method Methods 0.000 title abstract description 3
- 230000002265 prevention Effects 0.000 title description 5
- 239000007864 aqueous solution Substances 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 12
- -1 boron cations Chemical class 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 229910052796 boron Inorganic materials 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 150000001450 anions Chemical class 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 150000002484 inorganic compounds Chemical class 0.000 claims description 3
- 229910010272 inorganic material Inorganic materials 0.000 claims description 3
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 3
- 150000002823 nitrates Chemical class 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000013535 sea water Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002547 new drug Substances 0.000 claims description 2
- 150000002826 nitrites Chemical class 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 229910001427 strontium ion Inorganic materials 0.000 claims description 2
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229910001416 lithium ion Inorganic materials 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 229910052712 strontium Inorganic materials 0.000 abstract 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 2
- 239000013011 aqueous formulation Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- PWYYWQHXAPXYMF-UHFFFAOYSA-N strontium(2+) Chemical compound [Sr+2] PWYYWQHXAPXYMF-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8800119A FR2625679B1 (fr) | 1988-01-08 | 1988-01-08 | Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales |
| FR88/00119 | 1988-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02502913A true JPH02502913A (ja) | 1990-09-13 |
Family
ID=9362116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1500765A Pending JPH02502913A (ja) | 1988-01-08 | 1988-12-21 | 無機塩類および酢酸を主成分とする、ウイルス性疾患の予防および治療用の水性製剤 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0347448B1 (uk) |
| JP (1) | JPH02502913A (uk) |
| AT (1) | ATE76298T1 (uk) |
| AU (1) | AU612228B2 (uk) |
| DE (1) | DE3871384D1 (uk) |
| FR (1) | FR2625679B1 (uk) |
| LV (1) | LV5660A3 (uk) |
| OA (1) | OA09160A (uk) |
| RU (1) | RU1809765C (uk) |
| UA (1) | UA13377A (uk) |
| WO (1) | WO1989006133A1 (uk) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU627309B2 (en) * | 1989-05-26 | 1992-08-20 | Terumo Kabushiki Kaisha | Preparation for blood dialysis and method for production thereof |
| EP0401445B1 (fr) * | 1989-05-31 | 1991-12-18 | Alix-Roland Commin | Préparation aqueuse à base de sels minéraux et d'acide acétique pour la prévention et le traitement des maladies virales |
| DE69432208T2 (de) * | 1993-11-22 | 2003-12-11 | Bio Life Internat Ag Zug | Präparat zur Behandlung von Akne, seborrhoischer Dermatitis und anderen Hautkrankheiten |
| DE4441483C1 (de) * | 1994-11-22 | 1996-04-04 | Gsf Forschungszentrum Umwelt | Verwendung von bio-assimilierbaren Borverbindungen |
| US7404967B2 (en) | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
| US6048553A (en) * | 1997-03-17 | 2000-04-11 | Macquarie Veterinary Supplies Pty Ltd | Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases |
| AU772096B2 (en) * | 2000-03-14 | 2004-04-08 | Sumika Enviro-Science Co., Ltd. | Method for denaturing allergens |
| GB0515112D0 (en) * | 2005-07-25 | 2005-08-31 | Remedy Res Ltd | Compositions for treating psychiatric conditions |
| FR2926465B1 (fr) * | 2008-01-17 | 2016-08-12 | Alix Roland Commin | Composition anti-virale notamment le sida |
| WO2011010000A1 (fr) * | 2009-07-22 | 2011-01-27 | Alix Roland Commin | Composition antivirale et retrovirale notamment pour le traitement du sida |
| DE102016117947A1 (de) * | 2016-09-23 | 2018-03-29 | Quality Pure Co., Ltd. | Mit Magnesium hoch konzentrierte Flüssigkeit und System, zum Mischen von Trinkwasser mit einer hohen Konzentration von Magnesium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3676553A (en) * | 1969-12-15 | 1972-07-11 | Cybersol | Therapeutic composition |
| FR2108935A1 (en) * | 1970-10-21 | 1972-05-26 | Destal Guyonnaud Michele | Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals |
-
1988
- 1988-01-08 FR FR8800119A patent/FR2625679B1/fr not_active Expired - Fee Related
- 1988-12-21 AU AU29081/89A patent/AU612228B2/en not_active Ceased
- 1988-12-21 WO PCT/FR1988/000626 patent/WO1989006133A1/fr active IP Right Grant
- 1988-12-21 JP JP1500765A patent/JPH02502913A/ja active Pending
- 1988-12-21 EP EP89900834A patent/EP0347448B1/fr not_active Expired - Lifetime
- 1988-12-21 UA UA4742196A patent/UA13377A/uk unknown
- 1988-12-21 DE DE8989900834T patent/DE3871384D1/de not_active Expired - Lifetime
- 1988-12-21 AT AT89900834T patent/ATE76298T1/de active
-
1989
- 1989-09-07 RU SU894742196A patent/RU1809765C/ru active
- 1989-09-12 OA OA59643A patent/OA09160A/xx unknown
-
1993
- 1993-12-21 LV LV931354A patent/LV5660A3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2625679B1 (fr) | 1990-02-09 |
| AU612228B2 (en) | 1991-07-04 |
| ATE76298T1 (de) | 1992-06-15 |
| DE3871384D1 (de) | 1992-06-25 |
| EP0347448B1 (fr) | 1992-05-20 |
| UA13377A (uk) | 1997-02-28 |
| FR2625679A1 (fr) | 1989-07-13 |
| EP0347448A1 (fr) | 1989-12-27 |
| RU1809765C (ru) | 1993-04-15 |
| LV5660A3 (lv) | 1994-10-20 |
| OA09160A (fr) | 1992-03-31 |
| AU2908189A (en) | 1989-08-01 |
| WO1989006133A1 (fr) | 1989-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH02502913A (ja) | 無機塩類および酢酸を主成分とする、ウイルス性疾患の予防および治療用の水性製剤 | |
| RU94045798A (ru) | Стереоизомеры итраконазола или саперконазола, способ их получения, их комплексы и способ получения, фармацевтическая композиция на их основе и ее получение, способ получения водных растворов с повышенной концентрацией итраконазола или саперконазола | |
| PE20001644A1 (es) | Composicion de un derivado de (5-aril-1,2,4-tiadiazol)-3-il tiourea o un derivado de (5-aril-1,2,4-tiadiazol)-3-il urea para tratar infecciones virales | |
| NO176389B (no) | Fremgangsmåte ved fremstilling av vandig folinatlösning stabil ved kjöleskapstemperatur | |
| KR950703988A (ko) | 긴 보장기간을 갖는 g-csf의 수성 약제 조성물(aqueous pharmaceutical preparations of g-csf whth a long shelf life) | |
| KR900015722A (ko) | N-(3,4-디메톡시신나모일) 안트라닐산을 함유하는 약제 조성물 | |
| HUP0002754A2 (hu) | (1S,4R)-cisz-4-[2-amino-6-(ciklopropil-amino)-9H-purin-9-il]-2-ciklopentén-1-metanol-hemiszulfát, eljárás előállítására, ezt tartalmazó gyógyszerkészítmény, valamint intermedierek | |
| IT8322623A1 (it) | Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina | |
| JPH0283318A (ja) | 安定な点眼剤 | |
| PE20030092A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio | |
| JPH09510989A (ja) | 安定なフォリン酸塩水溶液 | |
| DE69400190D1 (de) | Verfahren zum herstellen von arzneizusammensetzungen, die vecuroniumbromid enthalten | |
| US2644782A (en) | Aureomycin for injection | |
| JPS61218522A (ja) | 中性乃至弱アルカリ性で安定な水酸化鉄コロイド溶液 | |
| US2207074A (en) | Oxygen generating composition | |
| US3347746A (en) | Injectable solution of an amine salt of a radiopaque iodinated organic acid containing calcium ions | |
| JPS62265220A (ja) | １，４−ジヒドロキシ−５，８−ビス〔２−（２−ヒドロキシエチルアミノ）−エチルアミノ〕アントラキノン二塩酸塩の安定な注射用医薬配合物 | |
| US2667440A (en) | Stabilized aqueous solutions of paraminosalicylic acid salts | |
| AU534886B2 (en) | Solutions of canrenoic acid and furosemide salts | |
| KR940002268A (ko) | 21-클로로-프레그난 유도체 | |
| NO116683B (uk) | ||
| KR840001508B1 (ko) | 즉시 사용할 수 있는 주사용 수용액의 제조방법 | |
| JPS594416B2 (ja) | フエニレフリンルイノ アンテイカホウ | |
| US2999050A (en) | Stable ethaverine hydrochloride solutions | |
| US3271251A (en) | Germ-counteracting compositions |